GlassScriptPhysician profile
Thomas R Troost
NPI 1457355711
$647.24
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.50 · 2022: $164 · 2023: $134 · 2024: $31.20 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $196.63 | 2019-2025 | Dupixent |
| Optinose US, INC. | $139.66 | 2019-2023 | |
| Integra Lifesciences Corporation | $87.44 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $40.59 | 2025 | Trumatch |
| Aerin Medical INC. | $28.40 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $28.14 | 2025 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $26.24 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $24.20 | 2022 | |
| Hologic Sales and Service, LLC | $22.53 | 2023 | Coolseal Generator |
| Glaxosmithkline, LLC. | $19.82 | 2022 | |
| Smith+Nephew, INC. | $18.25 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Troost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.